NO994480L - Lipase-katalysert dynamisk omdanning av isoxazolin-tioester til isoxazolin-karboksylsyrer - Google Patents

Lipase-katalysert dynamisk omdanning av isoxazolin-tioester til isoxazolin-karboksylsyrer

Info

Publication number
NO994480L
NO994480L NO994480A NO994480A NO994480L NO 994480 L NO994480 L NO 994480L NO 994480 A NO994480 A NO 994480A NO 994480 A NO994480 A NO 994480A NO 994480 L NO994480 L NO 994480L
Authority
NO
Norway
Prior art keywords
isoxazoline
lipase
thioester
carboxylic acids
dynamic conversion
Prior art date
Application number
NO994480A
Other languages
English (en)
Norwegian (no)
Other versions
NO994480D0 (no
Inventor
Lin-Hua Zhang
Luigi Anzalone
Jaan A Pesti
Jianguo Yin
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO994480D0 publication Critical patent/NO994480D0/no
Publication of NO994480L publication Critical patent/NO994480L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO994480A 1997-03-26 1999-09-16 Lipase-katalysert dynamisk omdanning av isoxazolin-tioester til isoxazolin-karboksylsyrer NO994480L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4210997P 1997-03-26 1997-03-26
PCT/US1998/005903 WO1998042687A1 (en) 1997-03-26 1998-03-26 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids

Publications (2)

Publication Number Publication Date
NO994480D0 NO994480D0 (no) 1999-09-16
NO994480L true NO994480L (no) 1999-09-16

Family

ID=21920103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994480A NO994480L (no) 1997-03-26 1999-09-16 Lipase-katalysert dynamisk omdanning av isoxazolin-tioester til isoxazolin-karboksylsyrer

Country Status (20)

Country Link
US (1) US6022977A (hu)
EP (1) EP0971906A1 (hu)
JP (1) JP2001520672A (hu)
KR (1) KR20010005493A (hu)
CN (1) CN1251095A (hu)
AU (1) AU741040B2 (hu)
BR (1) BR9811255A (hu)
CA (1) CA2283234A1 (hu)
EA (1) EA001970B1 (hu)
EE (1) EE9900434A (hu)
HU (1) HUP0001264A3 (hu)
IL (1) IL132004A0 (hu)
LT (1) LT4674B (hu)
LV (1) LV12431B (hu)
NO (1) NO994480L (hu)
NZ (1) NZ500388A (hu)
PL (1) PL336008A1 (hu)
SI (1) SI20027A (hu)
SK (1) SK131599A3 (hu)
WO (1) WO1998042687A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803513B1 (fr) * 2000-01-12 2003-12-19 Oreal Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l'aspect papyrace de la peau
US6624311B2 (en) 2000-10-27 2003-09-23 Bristol-Myers Squibb Pharma Company Enantioselective enzymatic aminolysis of a racemic 2-isoxazolylacetate alkyl ester
GB0306267D0 (en) 2003-03-19 2003-04-23 Ineos Fluor Ltd Process
CN101643757B (zh) * 2009-09-07 2011-10-19 浙江大学 光学纯n-取代-吗啉-3-酮-2-乙酸的制备方法
ES2846833T3 (es) 2016-07-18 2021-07-29 Janssen Pharmaceutica Nv Ligandos de obtención de imágenes de tau por PET

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256898A (en) * 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4970297A (en) * 1987-03-13 1990-11-13 Syntex (U.S.A.) Inc. Transglutaminase inhibitors
US4933464A (en) * 1988-04-25 1990-06-12 W. R. Grace & Co.-Conn. Process for forming 3-phenylisoxazolines and 3-phenylisoxazoles
US4952700A (en) * 1988-04-25 1990-08-28 W.R. Grace & Co.-Conn. Preparation of isoxazolines and isoxazoles
US5108916A (en) * 1989-06-05 1992-04-28 Rhone-Poulenc Rorer, S.A. Process for stereoselectively hydrolyzing, transesterifying or esterifying with immobilized isozyme of lipase from candida rugosa
CA2023856A1 (en) * 1989-09-26 1991-03-27 Jeffrey M. Howell Enzymatic resolution process
AT398081B (de) * 1991-04-29 1994-09-26 Chemie Linz Gmbh Verfahren zur enzymatischen hydrolyse eines carbonsäurederivates
GB9304351D0 (en) * 1993-03-03 1993-04-21 Chiros Ltd Arylalkanoic acid resolution and microorganisms for use therein
US5489562A (en) * 1993-08-30 1996-02-06 Rohm And Haas Company Herbicide comprising acivicin and α-methyl derivatives thereof
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5446056A (en) * 1993-11-24 1995-08-29 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists
RU2149871C1 (ru) * 1993-11-24 2000-05-27 Дзе Дюпон Мерк Фармасьютикал Компани Изоксазолины и изоксазолы, способ подавления агрегации тромбоцитов, фармацевтическая композиция, подавляющая агрегацию тромбоцитов
EP0730587B1 (en) * 1993-11-26 1999-12-08 Pfizer Inc. 3-phenyl-2-isoxazolines as antiinflammatory agents
EP0730588B1 (en) * 1993-11-26 1997-07-02 Pfizer Inc. Isoxazoline compounds as antiinflammatory agents
DE69503769T2 (de) * 1994-03-09 1998-12-03 Pfizer Inc., New York, N.Y. Isoxazoline verbindung zur hemmung tnf-freigabe

Also Published As

Publication number Publication date
US6022977A (en) 2000-02-08
HUP0001264A2 (hu) 2000-08-28
LV12431B (en) 2000-07-20
WO1998042687A1 (en) 1998-10-01
HUP0001264A3 (en) 2002-02-28
LT99112A (en) 2000-02-25
AU741040B2 (en) 2001-11-22
NO994480D0 (no) 1999-09-16
EP0971906A1 (en) 2000-01-19
CA2283234A1 (en) 1998-10-01
PL336008A1 (en) 2000-06-05
KR20010005493A (ko) 2001-01-15
IL132004A0 (en) 2001-03-19
EA001970B1 (ru) 2001-10-22
LT4674B (lt) 2000-07-25
BR9811255A (pt) 2000-07-18
LV12431A (lv) 2000-02-20
CN1251095A (zh) 2000-04-19
JP2001520672A (ja) 2001-10-30
EE9900434A (et) 2000-04-17
NZ500388A (en) 2001-06-29
SK131599A3 (en) 2001-05-10
AU6941498A (en) 1998-10-20
SI20027A (sl) 2000-02-29
EA199900874A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
AU7221494A (en) Process for preparing fatty acid alkyl esters
BR9808785A (pt) Processos para produzir ésteres de citrato
Danieli et al. Chemo‐enzymatic Synthesis of 6 ″‐O‐(3‐Arylprop‐2‐enoyl) Derivatives of the Flavonol Glucoside Isoquercitrin
NO994480L (no) Lipase-katalysert dynamisk omdanning av isoxazolin-tioester til isoxazolin-karboksylsyrer
EP0501310B1 (en) Method for optical resolution of corey lactone diols
ES8606356A1 (es) Procedimiento para preparar noroximorfona a partir de morfi-na
FR2743084B1 (fr) Procede de fabrication de produits solides par esterification des acides gras libres en presence de catalyseurs acides
KR880003896A (ko) 환상지방족 알코올의 아미노산 에스테르, 그 제조방법 및 약제로서의 그 용도
EP0057045A3 (en) Derivatives of 5-hydroxy-tetrahydro-2-furanone
NO932742D0 (no) Derivater av kininsyre og en fremgangsmaate for deres fremstilling
DK0477347T3 (da) Fremgangsmåde til fremstilling af celluloseestere ved anvendelse af carboxylsyrer
HK1003785A1 (en) Mono esters of dicarboxylic acids their preparation and use
RU94015601A (ru) Способ получения энантиомеров арилалкановых кислот
HUP9802532A3 (en) Isolation of clavulanic acid from fermentation broth by ultrafiltration
HUT58089A (en) Process for producing 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic aci derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CA2120812A1 (en) Improved process for manufacturing l-(-)-carnitine from a waste product having opposite configuration
FI935712A0 (fi) Foerfarande foer enzymatisk framstaellning av optiskt aktiva transglycidsyraestrar
ES2002923A6 (es) Procedimiento para preparar 4-hidroxi-2-oxo-pirrolidin-1-il-acetamida.
AU2014388A (en) Fluorobenzyl esters of cyclopropane carboxylic acids useful as insecticides
Ozegowski et al. Enzymes in Organic Synthesis, 18. Lipase‐catalyzed Asymmetric Alcoholysis of 3‐Substituted Pentanedioic Anhydrides
DK570282A (da) Fremgangsmaade til fremstilling af et indolderivat
KR100463878B1 (ko) 효소적 방법에 의한 광학활성 ｎ-메틸-3-히드록시-3-페닐프로판아미드 및 이의 에스테르 제조 방법
NO944336L (no) Enzymatisk fremgangsmåte for fremstilling av S-6-metoksy- -metyl-2-naftaleneddiksyre
AU3580889A (en) Process for the enzymatic resolution of the optical isomers of racemic ester derivatives of 3-mercapto-2-alkyl-propionic acid
RU95108544A (ru) Способы получения промежуточных соединений бета-метилкарбапенемов, промежуточные соединения

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application